Stocktoria
VITASPRING BIOMEDICAL CO. LTD. VSBC
VITASPRING BIOMEDICAL CO. LTD. (VSBC) earns a Piotroski F-score of 4/9 (mixed financial health). It does not currently pay a dividend.
Quality score trend · recomputed for each fiscal year
Each year's score is computed from that year's filing — a rising Piotroski F or Altman Z″ means improving financial health, a fall is worth a look.
How it ranks in Services · percentile among 982 companies
Percentile vs other Services companies we cover — e.g. “stronger than 90%” means only 10% score higher on that measure.
Piotroski F breakdown · 4/9 tests passed
- Positive return on assets
- Positive operating cash flow
- Rising ROA
- Cash flow exceeds net income
- Lower long-term debt
- Rising current ratio
- No share dilution
- Rising gross margin
- Rising asset turnover
Sector peers · similar-size Services companies compare side by side →
| Ticker | Company | Piotroski F | Altman Z″ | P / E | Revenue growth |
|---|---|---|---|---|---|
| VSBC | VITASPRING BIOMEDICAL CO. LTD. | 4/9 | — | — | — |
| IQV | IQVIA HOLDINGS INC. | 5/9 | 1.14 | 23.5 | +5.9% |
| ICLR | ICON PLC | 6/9 | 2.1 | 56.7 | +0.8% |
| INCY | INCYTE CORP | 6/9 | 7.9 | 17.7 | +21.2% |
| CRL | CHARLES RIVER LABORATORIES INTERNATIONAL, INC. | 4/9 | 1.81 | — | -0.9% |
| MEDP | Medpace Holdings, Inc. | 6/9 | 0.2 | 33.4 | +20% |
| NRC | NRC HEALTH | 3/9 | 0.03 | — | -4% |
About VITASPRING BIOMEDICAL CO. LTD.
VitaSpring Biomedical Co. Ltd., a development-stage biomedical company, engages in the research, development, and commercialization of wellness and healthy lifestyle products. It focuses on the development of cell-based medical technologies for use in regenerative medicine, preventive health care, beauty, and anti-aging applications. The company is also involved in the development of cell medical treatment. The company was formerly known as Shemn Corp. and changed its name to VitaSpring Biomedical Co. Ltd. in February 2020. VitaSpring Biomedical Co. Ltd. was incorporated in 2016 and is based in Riverside, California.
FAQ
Is VSBC financially healthy?
VITASPRING BIOMEDICAL CO. LTD.'s Piotroski F-score is 4/9 (8–9 is excellent, 0–3 weak).
Does VSBC pay a dividend?
No, VITASPRING BIOMEDICAL CO. LTD. does not currently pay a dividend.
Is VSBC a good stock to buy?
Stocktoria doesn't give buy or sell advice, but here is the data on VITASPRING BIOMEDICAL CO. LTD.: a Piotroski F-score of 4/9. Weigh these quality and valuation signals against your own goals.
Computed from company filings · US · as of 2026-01-31. Facts plus Stocktoria's own computed scores — not investment advice.